Compound Summary
salicylate
Compound Information
salicylate
Compound Name: | salicylate |
Compound CID: | 54675850 |
Synonyms: | salicylate 2-Hydroxybenzoate o-Hydroxybenzoate 2-carboxyphenolate hydroxybenzoate More... |
Iupac Name: | 2-carboxyphenolate |
InChI: | InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)/p-1 |
InChIKey: | YGSDEFSMJLZEOE-UHFFFAOYSA-M |
Canonical Smiles: | C1=CC=C(C(=C1)C(=O)O)[O-] |
Isomeric Smiles: | C1=CC=C(C(=C1)C(=O)O)[O-] |
Molecular Weight: | 137.11 |
Molecular Formula: | C7H5O3- |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
salicylate
Molecular Weight: | 137.11 |
Molecular Formula: | C7H5O3- |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 10 |
Complexity: | 133 |
Synonyms
salicylate
| salicylate | salicylate |
|---|---|
salicylate |
2-Hydroxybenzoate |
o-Hydroxybenzoate |
2-carboxyphenolate |
hydroxybenzoate |
2-Hydroxybenzoic acid ion(1-) |
2-hydroxy-benzoate |
63-36-5 |
Salicylate ion |
Salicylate anion |
Benzoic acid, 2-hydroxy-, ion(1-) |
25496-36-0 |
o-Hydroxybenzoate anion |
Salicylates |
Salicylic acid, ion(1-) |
NCGC00178624-02 |
o-Hydrobenzoate |
2-Oxylatobenzoate |
3twp |
o-Hydrobenzoic Acid |
POLYSALICYLATE |
2y7k |
2y7p |
2y7w |
3gf2 |
2-Hydroxybenzoate (Na+) |
2-Hydroxybenzoic acid anion |
ACS No 10 |
BDBM85513 |
CHEBI:30762 |
DTXSID70948389 |
NSC_5900 |
BBL000698 |
MFCD00984876 |
STK372903 |
AKOS005447222 |
CAS_54-21-7 |
NCGC00178624-03 |
3198-EP2289876A1 |
3198-EP2298777A2 |
3198-EP2314295A1 |
3320-EP2269978A2 |
3320-EP2269985A2 |
3320-EP2269991A2 |
3320-EP2272847A1 |
3320-EP2275102A1 |
3320-EP2275420A1 |
3320-EP2277875A2 |
3320-EP2277876A1 |
3320-EP2280008A2 |
3320-EP2284150A2 |
3320-EP2284151A2 |
3320-EP2284152A2 |
3320-EP2284153A2 |
3320-EP2284155A2 |
3320-EP2284156A2 |
3320-EP2284164A2 |
3320-EP2284170A1 |
3320-EP2284178A2 |
3320-EP2284179A2 |
3320-EP2287140A2 |
3320-EP2287148A2 |
3320-EP2287150A2 |
3320-EP2289871A1 |
3320-EP2292590A2 |
3320-EP2292593A2 |
3320-EP2292595A1 |
3320-EP2292614A1 |
3320-EP2295412A1 |
3320-EP2295413A1 |
3320-EP2295416A2 |
3320-EP2295419A2 |
3320-EP2295432A1 |
3320-EP2295550A2 |
3320-EP2298732A1 |
3320-EP2298735A1 |
3320-EP2298743A1 |
3320-EP2298748A2 |
3320-EP2298764A1 |
3320-EP2298765A1 |
3320-EP2298777A2 |
3320-EP2301534A1 |
3320-EP2301912A2 |
3320-EP2301913A1 |
3320-EP2301914A1 |
3320-EP2301916A2 |
3320-EP2301927A1 |
3320-EP2305243A1 |
3320-EP2305260A1 |
3320-EP2305637A2 |
3320-EP2305671A1 |
3320-EP2305688A1 |
3320-EP2308832A1 |
3320-EP2308863A1 |
3320-EP2311451A1 |
3320-EP2311796A1 |
3320-EP2311797A1 |
3320-EP2311798A1 |
3320-EP2311799A1 |
3320-EP2311825A1 |
3320-EP2311835A1 |
3320-EP2311842A2 |
3320-EP2314295A1 |
3320-EP2314578A1 |
3320-EP2316450A1 |
3320-EP2316470A2 |
3320-EP2316835A1 |
AB00053542_03 |
Q3469744 |
Experimental Data
salicylate
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 1.000000000000000 | mM | 15.100000000000000 | 16.900000000000000 | 12.000000000000000 | S | N2 | 22866967 | Active | ||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 14.800000000000000 | 18.100000000000000 | 22.000000000000000 | S | N2 | 22866967 | Active | ||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 15.700000000000000 | 17.600000000000000 | 12.000000000000000 | S | N2 | 22866967 | Active |
Experimental Data Visualization
salicylate
Statistics Data
salicylate
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 22.000000000000000 | 1 | 3 |
Statistics Data Visualization
salicylate
